Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
Clinical Chemistry|October 20, 2018
A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of DiseasePedrum Mohammadi-Shemirani, Jennifer Sjaarda, Hertzel C Gerstein, et al.
Hematological Oncology|November 1, 1990
Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisoloneJ B Bell, B C Millar, A Montes-Borinaga, et al.
Seminars in Hematology|October 1, 1996
Idarubicin, high-dose cytarabine, and etoposide for induction of remission in acute leukemiaJ Mehta, R Powles, S Singhal, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patientsB Sirohi, R Powles, J Mehta, et al.
British Journal of Haematology|June 1, 1990
Thrombocytopenia after bone marrow transplantation for leukaemia: changes in megakaryocyte growth and growth-promoting activityJ A Adams, A A Gordon, Y Z Jiang, et al.
Bone Marrow Transplantation|October 6, 1997
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatmentR Powles, N Raje, S Milan, et al.
Bone Marrow Transplantation|October 16, 2002
Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'?R Powles, B Sirohi, S Kulkarni, et al.
Bone Marrow Transplantation|March 14, 2000
Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantationS Singhal, R Powles, S Kulkarni, et al.
Lancet (London, England)|April 19, 2000
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trialR Powles, J Mehta, S Kulkarni, et al.
British Journal of Haematology|August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up resultsD Cunningham, R Powles, J Malpas, et al.
Pageof 19